Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Isoliquiritigenin Market by Type (Less Than 98%, More Than 98%), By Application (Antidiabetic, Antitumour, Antioxidant, Anti-Inflammatory, Antimutagenic, Antifungal) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Isoliquiritigenin Market by Type (Less Than 98%, More Than 98%), By Application (Antidiabetic, Antitumour, Antioxidant, Anti-Inflammatory, Antimutagenic, Antifungal) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 359392 4200 Chemical & Material 377 139 Pages 4.9 (47)
                                          

Market Overview:


The global isoliquiritigenin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for isoliquiritigenin from various applications, increasing research and development activities for isoliquiritigenin, and growing awareness about the benefits of isoliquiritigenin. However, factors such as high cost of production and limited availability could restrain the growth of this market.


Global Isoliquiritigenin Industry Outlook


Product Definition:


Isoliquiritigenin is a flavonoid found in licorice. It has anti-inflammatory and antiviral properties.


Less Than 98%:


Isoliquiritigenin is a bioactive compound, extracted from plant ginseng. It has the ability to inhibit angiogenesis and metastasis of tumor by blocking the formation of new blood vessels by endothelial cells. The compound also possesses anti-inflammatory properties that can be utilized in treating inflammatory skin diseases such as atopic dermatitis and psoriasis through topical application.


More Than 98%:


More than 98% is a technical term used for the concentration of a flavonoid in plant extracts. More than 98% of total isoliquiritigenin content found in Chia seeds is present in the form of bound fraction on account of its hydrophobic nature. The percentage value “98” represents the weight ratio between free and bound fraction, which varies from 0.1 to 10 depending upon various factors such as extraction method, solvent type and temperature, among others.


Application Insights:


Isoliquiritigenin is widely used in the form of a dietary supplement and as an additive in the pharmaceutical industry. The antioxidant property of isoliquiritigenin has led to its extensive use as an additive in nutritional supplements. In addition, it also finds application as a food additive and preservative for various food products such as cheese, chocolate bars, juices etc.


The antimicrobial activity of isoliquiritigenin has resulted in its extensive use against bacteria including Staphylococcus aureus, Escherichia coli O157:H7 (Shiga toxin-producing E.coli), Listeria monocytogenes (listeriosis) etc., It is also used against fungal infections such as Candida albicans & Torulopsis glabrata (fungal ulcers). Other than these applications, it is also used for animal feed purposes owing to increased weight gain by animals treated with it compared to untreated animals.


Regional Analysis:


North America is anticipated to be the largest market over the forecast period owing to high product demand as a result of rising consumer awareness regarding health and well-being. The region accounted for 39.1% share in terms of revenue in 2017, which is attributed to growing geriatric population and increasing healthcare expenditure. Moreover, presence of key manufacturers such as Cargill Inc., Roquette LLC, and FMC Corporation will boost market growth over the forecast period.


Asia Pacific is expected to register significant growth due to rise in disposable income coupled with improving healthcare infrastructure leading towards economic development especially in emerging countries such as China.


Growth Factors:


  • Increasing demand for natural and organic products
  • Rising awareness about the health benefits of Isoliquiritigenin
  • Growing popularity of herbal supplements and remedies
  • Proliferation of online retail channels
  • Expanding applications for Isoliquiritigenin in food, cosmetics, and pharmaceuticals

Scope Of The Report

Report Attributes

Report Details

Report Title

Isoliquiritigenin Market Research Report

By Type

Less Than 98%, More Than 98%

By Application

Antidiabetic, Antitumour, Antioxidant, Anti-Inflammatory, Antimutagenic, Antifungal

By Companies

BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Targetmol, Ivy Fine Chemicals, Cayman Chemical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

139

Number of Tables & Figures

98

Customization Available

Yes, the report can be customized as per your need.


Global Isoliquiritigenin Market Report Segments:

The global Isoliquiritigenin market is segmented on the basis of:

Types

Less Than 98%, More Than 98%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Antidiabetic, Antitumour, Antioxidant, Anti-Inflammatory, Antimutagenic, Antifungal

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BOC Sciences
  2. BLDpharm
  3. Pharmaffiliates
  4. ChemScence
  5. AdooQ BioScience
  6. ApexBio Technology
  7. EXTRASYNTHESE
  8. Merck
  9. Abcam
  10. Targetmol
  11. Ivy Fine Chemicals
  12. Cayman Chemical

Global Isoliquiritigenin Market Overview


Highlights of The Isoliquiritigenin Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Less Than 98%
    2. More Than 98%
  1. By Application:

    1. Antidiabetic
    2. Antitumour
    3. Antioxidant
    4. Anti-Inflammatory
    5. Antimutagenic
    6. Antifungal
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Isoliquiritigenin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Isoliquiritigenin Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Isoliquiritigenin is a natural compound found in plants. It has been shown to have anti-inflammatory and antioxidant properties.

Some of the major players in the isoliquiritigenin market are BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Targetmol, Ivy Fine Chemicals, Cayman Chemical.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Isoliquiritigenin Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Isoliquiritigenin Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Isoliquiritigenin Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Isoliquiritigenin Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Isoliquiritigenin Market Size & Forecast, 2020-2028       4.5.1 Isoliquiritigenin Market Size and Y-o-Y Growth       4.5.2 Isoliquiritigenin Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Less Than 98%
      5.2.2 More Than 98%
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Antidiabetic
      6.2.2 Antitumour
      6.2.3 Antioxidant
      6.2.4 Anti-Inflammatory
      6.2.5 Antimutagenic
      6.2.6 Antifungal
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Isoliquiritigenin Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Isoliquiritigenin Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Less Than 98%
      9.6.2 More Than 98%
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Antidiabetic
      9.10.2 Antitumour
      9.10.3 Antioxidant
      9.10.4 Anti-Inflammatory
      9.10.5 Antimutagenic
      9.10.6 Antifungal
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Less Than 98%
      10.6.2 More Than 98%
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Antidiabetic
      10.10.2 Antitumour
      10.10.3 Antioxidant
      10.10.4 Anti-Inflammatory
      10.10.5 Antimutagenic
      10.10.6 Antifungal
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Less Than 98%
      11.6.2 More Than 98%
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Antidiabetic
      11.10.2 Antitumour
      11.10.3 Antioxidant
      11.10.4 Anti-Inflammatory
      11.10.5 Antimutagenic
      11.10.6 Antifungal
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Less Than 98%
      12.6.2 More Than 98%
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Antidiabetic
      12.10.2 Antitumour
      12.10.3 Antioxidant
      12.10.4 Anti-Inflammatory
      12.10.5 Antimutagenic
      12.10.6 Antifungal
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Less Than 98%
      13.6.2 More Than 98%
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Antidiabetic
      13.10.2 Antitumour
      13.10.3 Antioxidant
      13.10.4 Anti-Inflammatory
      13.10.5 Antimutagenic
      13.10.6 Antifungal
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Isoliquiritigenin Market: Competitive Dashboard
   14.2 Global Isoliquiritigenin Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 BOC Sciences
      14.3.2 BLDpharm
      14.3.3 Pharmaffiliates
      14.3.4 ChemScence
      14.3.5 AdooQ BioScience
      14.3.6 ApexBio Technology
      14.3.7 EXTRASYNTHESE
      14.3.8 Merck
      14.3.9 Abcam
      14.3.10 Targetmol
      14.3.11 Ivy Fine Chemicals
      14.3.12 Cayman Chemical

Our Trusted Clients

Contact Us